President, CEO, and Advisory Board Member with two decades of life sciences experience. Dynamic leader with focus on building high performing work culture. Strategic collaborator, with strong track record in starting and scaling businesses globally.
Overview
18
18
years of professional experience
Work History
President & CEO
STATinMED
Dallas, TX
05.2024 - Current
Grew revenue by 60% in 2025
Grew EBITDA by 55% in 2025
Developed new suite of digital market access products to adapt/adjust to changing life sciences landscape
Driving enterprise level sales growth through thought leadership
Rebranding our products to streamline naming and strategic vertical within pharma/device/biotech
Engaging with investors to identify new areas of opportunity for M&A
Identifying key strategic healthcare partners to expand offerings
CCO/COO
STATinMED
Dallas, TX
11.2021 - 05.2024
Engaging with investors to establish strategic growth, operations, and sales plan
Created Client Engagement division to drive project/customer service excellence
Led rebranding of company website, logo, content development
Developed enterprise/platform offering, including the successful sale of first enterprise deal in history of STATinMED for $1.6M
Sales lead on channel partner deal for $1.4M; recurring, quarterly revenue w/100% margin
Working with CEO to create additional value for company, specific to new product offerings
Grew customer footprint from large pharma only, to small & medium Pharma, and non-Pharma (from 15 to 42 customers)
Senior Vice President, Corporate Development & Operations
STATinMED
Dallas, TX
11.2020 - 11.2021
Leading all operational aspects of the business including research and programming.
Leading all corporate development, sales, and marketing functions.
Q2 2021 sales = most in the history of STATinMED with 80% growth YoY
Established 7 person team of highly skilled, highly motivated sales executives
Sales enablement division created to drive proposals, sales support, patient counts
Operational turnaround resulted in consistent revenue model with monthly targets hit in consecutive months from September to present.
Vice President, Business Development
STATinMED
Dallas, TX
02.2020 - 11.2020
Led team of BD executive in driving new business through insight centric approach
Added new data assets in oncology and EMR data
Went from $0 to $2M in 2020 at Gilead via multiple projects in partnership model
Established thought leadership presence for company through videos/blogs/publication planning
Identified key strategic partnerships with Parexel, Joint Man, Vanderbilt University, and M2GEN
Expanded account at Takeda beyond GI into oncology and rare heme
Began operational oversight of research and turned around failing revenue model
Senior Director, HEOR Operations
CONCERTO HEALTH AI
03.2019 - 02.2020
Establish operational processes for new HEOR project types
Implement work flows to support project work using Outcomes data products for nonsubscribers, not requiring custom curation
Implement work flows to support project work requiring incremental curation on subsets of Outcomes data product cases for subscribers
Implement new analytic models leveraging linked EMR-Claims data products
Management for statistical programming services
Establish and direct a pharma-facing FSP model to provide HEOR scientific and programming services
Build new processes to allow scalability of HEOR project work
Identify and hire the right people in US and off-shore to support new HEOR project models
Align operational processes with CSO to optimize scientific input into proposal and delivery of each project type
Work closely with CSO to scale the feasibility/proposal unit to increase flow of new proposals
Work with President, Sales VP, CSO and CFO to implement processes and systems coordinating proposals, backlog/pipeline, revenue forecasting and resource planning between sales/BD, HEOR operations and finance teams
Align and optimize processes with the HEOR scientific team as needed to meet delivery of project milestones, and adoption of Outcomes data products
Drive HEOR team adoption of new technology tools for HEOR adopted and implemented in the eureka platform
Direct Project Management team
Connect with other CHAI service areas as needed to align products and service offerings (e.g. Eureka platform team, Global Curation Services)
Contribute to achievement of Outcomes Science Bookings, NOR, GM and P&L goals.
Support President and CFO in monthly management reporting.
Director, Strategic Accounts
IQVIA (IMS-Quintiles)
Dallas, TX
03.2018 - 03.2019
Managing relationships and expanding accounts for drug wholesaler/suppliers
Verticals into HEOR, distribution sales, hub services, and analytics
Working strategically with customers to understand data needs
Developing reports to meet customer objectives based on data strategy
Expanding networks to identify areas of unmet opportunities for data and reports
Attending wholesaler/supplier sales meetings to partner with customers and better understand business needs
Growing account by expanding relationships outside of pharmacies, pharma, and physicians
Selling data, reporting, and insight-centric solutions
Head of Clinical Operations
Cardinal Health
Dallas, TX
10.2016 - 03.2018
Established new value proposition for Pharma Hub business, focused on analytics/data insights
Thought leadership development for new value prop including publications and presentations (Speaker at Pharma 4 and CBI Conferences)
Casting vision for integration of patient reported outcomes (PRO) and data aggregation product offerings into Pharma Hub space
Developing and selling PRO product offering as differentiator for Cardinal Hub
Working strategically with Pharma manufacturers to provide brand strategy solutions using Hub data
Rebuilding client relations group to drive consultative account management via data driven insights
Developing processes for sales pursuit, QBR meetings, report dissemination to clients
Responsible for Pharma Hub (Access and Patient Services-Sonexus) P&L analytics
Leading process optimization to drive EBIT
Ensuring interdepartmental efficiencies between IT, operations, finance, and sales
Facilitating interconnected communication across business
Director, HEOR
Cardinal Health
Dallas, TX
02.2015 - 10.2016
Responsible for management, fiscal growth, marketing plan, and operations of the Cardinal Health HEOR consulting business
Developed new product offerings in the HEOR space
Built new function of client relations/engagement within the business
Achieved profitability for first time in history of HEOR business at Cardinal Health (started in 2011)
Led turnaround of business, going from revenue of $2M to revenue of $7M, including GM increase from 0% to 136%
Led publications and thought leadership marketing strategy for Specialty Solutions division, increasing volume of acceptances by 125%
Selected as one of 32 Directors across the Cardinal Health enterprise to participate in the Innovate leadership development program for high potential-high performers.
Reviewed new business opportunities, oversight and accountability for project timelines, management of operations teams, support of physician leaders, and ensuring quality conduct and successful execution of Healthcare Analytics projects
Worked collaboratively with contracting, finance, and BD teams in order to manage timelines, and all needs related to the operations of projects
Planned FY budgets, revenue projections and assisted with forecasting of activities (costs) for clients
Worked proactively with the Business Development team to provide support on the offerings of the businesses, review of proposals, created scopes of work for vendors and clients and defined/refined service lines
Managed the business feasibility process, including use of multiple data assets and knowledge sources
Chief of Staff for Division President’s Operating Committee
Director, Scientific Communications
Cardinal Health
Dallas, TX
08.2013 - 02.2015
Established SciComm team as a go-to insight generating group, serving the Marketing Communications consulting business within Cardinal Health Specialty Solutions
Cardinal Health Specialty Solutions’ Rising Star for fiscal year 2014 (July ’13 to June ’14)
Developed insight driven lead marketing initiative to deliver analytics insights to support consulting business development/sales
Led, planned, and executed strategic publication planning effort across Pharma Specialty Solutions division, in collaboration with Chief Medical Officer
Executive Director and founder of FOCUS magazine, a Cardinal Health - HEOR bi-annual thought leadership marketing piece
Built cohesive, high-performing Scientific Communications team to serve Specialty Solutions division, and establish thought leadership in specialty drug market
Providing strategic, scientific vision for top-to-top executive meeting agendas with Pfizer, Genentech, Novartis, Sanofi, Amgen, and Astrazeneca
Establishing strategic meeting agendas for Division President’s Specialty Operating Committee
Chief of Staff for Division President’s Specialty Operating Committee
Developing relationships with clinical thought leaders in the oncology, hematology, and urology therapeutic areas arenas to stay current on clinical developments
Working cross functionally with all other Specialty Solutions business units to leverage insights from scientific communications for business development
Clinical Operations Manager
Orthofix
Lewisville, TX
04.2012 - 08.2013
Strategic scientific communication planning and execution for reimbursement presentations to medical directors (i.e. Blue Cross Blue Shield), and scientific presentations for global conferences and congresses
Presented clinical data at international research forums (i.e. World Forum for Spine Research – Helsinki)
One of two total (out of 800 employees) LEAN process efficiency award winners at OFIX – Purple Belt
Identifying and negotiating with CRO for post market studies to maintain CE mark
HEOR study planning and execution based on business needs, target journal etc.
Developed regional strategic marketing plan based on leveraging clinical data to target specific US areas
Worked closely with marketing department to develop key marketing materials for sales force focused on clinical data and publications
Identify products where published clinical data would increase market share
Planned and executed on strategies to publish retrospective clinical data to show evidence of value in products needing leverage
Senior Manager, Global Quality, Regulatory, and Clinical Affairs
Wright Medical Technology
Amsterdam
09.2011 - 03.2012
Led launch of Global Quality, Regulatory, and Clinical group based in Amsterdam
Resolved difficult compliance, clinical, and regulatory issues through successful coalition building
Led global, interdepartmental product obsolescence effort based on myriad of business concerns including gross profit margins and clinical trial costs
Designed and implemented clinical/regulatory strategies to obtain, maintain, and extend product registrations
Involved in the creation and submission of documents to global regulatory authorities and notified body (e.g. FDA, BSi etc.)
Served as a liaison with global regulatory authorities to develop effective relationships; Arranged and led meetings with global regulatory authorities
Developed clinical trial protocols for global studies to maintain CE mark
Participated in the assessment, qualification, and recommendation of clinical trial vendors (e.g., CROs, laboratories, etc.)
Monitored progress of clinical trials and how they are conducted, recorded and reported versus the protocol, standard operating procedures (SOP), good clinical practices (GCP), other applicable regulatory requirements and timelines
Led launch of global department of strategic scientific communications/HEOR group
Established strategies and tactics supporting core components of scientific communications, including: development of marketing materials, disease education programs, scientific exchange tools/resources, medical meeting/congress communications, publications and medically/scientifically oriented advisory boards
Established and maintained a global network of key opinion leaders, supplemented by functional relationships with key societies and organizations
Developed and led a comprehensive, global scientific communications strategy for launch of wound care product
Worked closely with Clinical, Regulatory, and R&D groups in EMEA to determine business needs via product optimization, gross margins, and market trends
Served as liaison to notified body in EMEA
Successful author of $2.4 million Department of Defense (DoD) grant for IDE clinical trial on calcium sulfate based bone void filler coated with tobramycin
Project lead on pre-IDE meeting, IDE submission, and negotiation with FDA on protocol for DoD study
Developed sales training program specific to publications/scientific communications
Developed online resource library as means to equip/educate sales force
Publications Manager
Wright Medical Technology
07.2009 - 03.2010
Planned for launch of Strategic Scientific Communications group within Clinical Affairs department
Worked closely with sales force to develop marketing/educational materials for Ortho Recon products
Met with key opinion leaders to discuss strategic publication plans
Helped drive important business objectives through publications on Ortho Recon products
Managed seven retrospective clinical trials, each resulting in manuscripts
Author and Project Director for grant application to Department of Defense resulting in $2.4 million for clinical trial to study open fracture wound treatment
Worked with Chief Compliance Officer to develop foundational procedures to plan launch of in-house publications group
Wrote and edited post market clinical follow up plans for dossier submissions to notified body in Europe
Clinical Project Manager
Exactech
Gainesville, FL
05.2008 - 06.2009
Designed educational curriculum for sales staff
Study manager for FDA regulated post market approval study and multiple clinical studies
Study monitor for FDA and non-FDA regulated clinical studies
Author and Project Director – Small Business Innovative Research (SBIR) Grant
$850k in funding
Initiated project ideas, and assembled team of scientists and product managers
Served as biostatistician for all company related clinical studies and preclinical analyses
Avoided 3rd party contracting and saved company over 35k in first year
Met with key opinion leaders to discuss both current and potential future projects
Wrote and edited 510k, and PMA submissions to FDA
Wrote and edited post market clinical follow up plans for dossier submissions to notified body in Europe
Education
Innovate – Cardinal Health Executive Program - undefined
Vanderbilt University
01.2016
Certificate in Finance and Accounting - undefined
Southern Methodist University
01.2015
PhD - Molecular Physiology
University of Florida
01.2008
MS - Clinical Physiology
George Washington University
01.2000
BS - Physiology
George Washington University
01.1997
Skills
Life Sciences
Customer Engagement
Conflict Resolution
EBITDA Improvement
High Performance Team Building
Coaching
Talent Identification
Private Equity
Operational Strategy
Advisory Board Experience
STATinMED, 2021-11-01
Iluria, 2025-02-01
CarePoint Solutions, 2025-01-01
Timeline
President & CEO
STATinMED
05.2024 - Current
CCO/COO
STATinMED
11.2021 - 05.2024
Senior Vice President, Corporate Development & Operations
STATinMED
11.2020 - 11.2021
Vice President, Business Development
STATinMED
02.2020 - 11.2020
Senior Director, HEOR Operations
CONCERTO HEALTH AI
03.2019 - 02.2020
Director, Strategic Accounts
IQVIA (IMS-Quintiles)
03.2018 - 03.2019
Head of Clinical Operations
Cardinal Health
10.2016 - 03.2018
Director, HEOR
Cardinal Health
02.2015 - 10.2016
Director, Scientific Communications
Cardinal Health
08.2013 - 02.2015
Clinical Operations Manager
Orthofix
04.2012 - 08.2013
Senior Manager, Global Quality, Regulatory, and Clinical Affairs